Apparatus for measuring glycation of red blood cells and glycated hemoglobin level using physical and electrical characteristics of cells, and related methods
US-12013404-B2 · Jun 18, 2024 · US
US2017188916A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017188916-A1 |
| Application number | US-201615395892-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 30, 2016 |
| Priority date | Dec 30, 2015 |
| Publication date | Jul 6, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises a biointerface layer which interfaces with a biological fluid containing the analyte to be measured. The biointerface layer can comprises a biointerface polymer, wherein the biointerface polymer comprises polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise a diffusion-resistance layer, which can comprise a base polymer having a lowest Tg of greater than −50 C.
Opening claim text (preview).
What is claimed is: 1 . A device for monitoring an analyte concentration, the device comprising: a transcutaneous sensor configured to generate a signal associated with a concentration of an analyte; and a sensing membrane located over the sensor, the sensing membrane comprising a diffusion-resistance layer comprising a base polymer having a lowest glass transition temperature as measured using ASTM D3418 of greater than −50° C. 2 . The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is greater than 0° C. 3 . The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 0° C. to 66° C. 4 . The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 20° C. to 60° C. 5 . The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 0° C. to 30° C. 6 . The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 30° C. to 60° C. 7 . The device of claim 1 , wherein the ultimate tensile strength of the base polymer is greater than 8250 psi. 8 . The device of claim 1 , wherein the base polymer is a segmented block copolymer. 9 . The device of claim 1 , wherein the base polymer comprises polyurethane and/or polyurea segments and one or more polycarbonate or polyester segments. 10 . The device of claim 1 , wherein the base polymer is a polyurethane copolymer chosen from a polycarbonate-urethane, polyether-urethane, and polyester-urethane. 11 . The device of claim 1 , wherein the base polymer comprises a polymer selected from epoxies, polystylene, polyoxymethylene, polysiloxanes, polyethers, polyacrylics, polymethacrylic, polyesters, polycarbonates, polyamide, poly(ether ketone), and poly(ether imide). 12 . The device of claim 1 , wherein the base polymer is substantially free of silicone. 13 . The device of claim 1 , wherein the diffusion-resistance layer further comprises a hydrophilic polymer. 14 . The device of claim 13 , wherein the hydrophilic polymer is selected from polyvinyl alcohol, polyethylene glycol, polyacrylamide, polyacetate, polyethylene oxide, polyethyleneamine, polyvinylpyrrolidone, polyoxzazloine, and mixtures thereof. 15 . The device of claim 13 , wherein the hydrophilic polymer is blended with the base polymer. 16 . The device of claim 13 , wherein the hydrophilic polymer is covalently bonded to the base polymer. 17 . The device of claim 13 , wherein the base polymer or hydrophilic polymer comprise a crosslinker or several crosslinkers, where in the crosslinker comprise a polymer or oligomer selected from polyfunctional isocynate, polyfunctional aziridine, polyfunctional carbodiimide. 18 . The device of claim 1 , wherein the diffusion-resistance layer comprises a blend of a polycarbonate-urethane base polymer and polyvinylpyrrolidone. 19 . The device of claim 1 , wherein the diffusion-resistance layer is from 0.01 μm to about 250 μm thick. 20 . The device of claim 1 , wherein the sensor has a drift of less than or equal to 10% over 10 days. 21 . The device of claim 1 , wherein the sensor comprises an electrode. 22 . The device of claim 1 , wherein the device is configured for continuous measurement of an analyte concentration. 23 . The device of claim 1 , wherein the analyte is glucose. 24 . The device of claim 1 , wherein the base polymer has an ultimate tensile strength as measured by ASTM D1708 that is greater than 6000 psi. 25 . The device of claim 1 , wherein the base polymer has a plurality of glass transition temperatures as measured using ASTM D3418. 26 . A device for monitoring an analyte concentration, the device comprising: a transcutaneous sensor configured to generate a signal associated with a concentration of an analyte; and a sensing membrane located over the sensor, the sensing membrane comprising a diffusion-resistance layer, wherein the diffusion-resistance layers comprises a polyurethane containing block copolymer, wherein the sensor has less than 10% change in signal at 2 hrs after start.
Magnoliopsida (dicotyledons) · CPC title
Polyethers containing oxyethylene units · CPC title
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone} · CPC title
Compositions of polycarbonates; Compositions of derivatives of polycarbonates · CPC title
Medicinal preparations containing inorganic active ingredients · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.